Teratogen update: Azathioprine and 6-mercaptopurine

Teratology

Volumn 65, Issue 5, 2002, Pages 240-261

  Polifka, Janine E ^a   Friedman, J M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE;

ANIMAL MODEL; AUTOIMMUNE DISEASE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG METABOLISM; GENETIC VARIABILITY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAUTERINE GROWTH RETARDATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PATIENT COUNSELING; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RAT; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZATHIOPRINE; CRICETINAE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; PATIENT EDUCATION; PREGNANCY; RABBITS; RATS; TERATOGENS; ZINC;

ANIMALIA;

EID: 0036255563     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10043     Document Type: Review

References (265)

1. National Transplantation Pregnancy Registry: Outcomes of pregnancies fathered by male transplant recipients
2. Embryotoxic and teratogenic effects of chemical carcinogens
3. Safety of azathioprine in pregnancy in inflammatory bowel disease
4. 65Zn distribution in the pregnant rat
5. 6-Mercaptopurine-induced alterations in mineral metabolism and teratogenesis in the rat
6. Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency
7. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients
8. National Transplantation Pregnancy Registry - Outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients
9. National Transplantation Pregnancy Registry: Analysis of pregnancy outcomes of female kidney recipients with relation to time interval from transplant to conception
10. Bioavailability of low-dose vs. high-dose 6-mercaptopurine
11. Hypertrophic cardiomyopathy associated with tacrolimus in pediatric transplant patients
12. Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children
13. Acute leukemia in pregnancy: Report of five cases treated with a combination which included a low dose of adriamycin
14. Immunological responses in an infant after cyclosporine A exposure during pregnancy
15. Successful pregnancy in acute leukemia
16. Conception and congenital abnormalities after chemotherapy for leukanemia
17. Pregnancy after liver transplantation
18. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: Relieved after a switch to Neoral
19. Pregnancy after cardiac transplantation
20. Four successful pregnancies following kidney transplantation
21. WAGR syndrome in a baby - The result of 6-MP treatment in a father affected by Crohn disease?
22. Pregnancy in kidney transplantation: Past and present experience
23. Effects of immunosuppressive drugs during pregnancy
24. The incorporation of 6-mercaptopurine-S-35 into the nucleic acids of sensitive and non-sensitive transplantable mouse tumors
25. Genetic toxicities of human teratogens
26. Ventricular parasystole in a newborn infant
27. Pregnancy outcome following cancer chemotherapy
28. Pregnancy following kidney homotransplantation from a non-twin. Report of a case with concurrent administration of azathioprine and prednisone
29. 6-Mercaptopurine: Cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts
30. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia
31. Management of inflammatory bowel disease
32. The influence of 6-mercaptopurine on rat placenta and fetus
33. Teratogenesis: Effects of substituted purines and the influence of 4-hydroxypyrazolopyrimidine in the rat
34. The effects of antirheumatic drugs on reproductive function
35. Definition of a teratogen and the relationship of teratogenicity to carcinogenicity
36. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. VI. Evidence for posttranscriptional modification of 6-thioguanosine residues in RNA from L5178Y cells treated with 6-mercaptopurine
37. Outcome of pregnancy following renal transplantation
38. Vertical development of the secondary palate in hamster embryos following exposure to 6-mercaptopurine
39. Renal allotransplantation during pregnancy. Successful outcome for mother, child, and kidney
40. Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring
41. Cesarean delivery in a patient with a transplanted heart
42. Uncomplicated vaginal delivery 14 months after cardiac transplantation
43. Pregnancy following cadaver kidney homotransplantation
44. Pregnancy after renal transplantation: 25 Years experience in Spain
45. Hepatitis related to cytomegalovirus infection in two patients with Crohn disease treated with azathioprine
46. Antineoplastic agents
47. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients
48. The teratogenic effects of the recent drugs active in cancer chemotherapy
49. Successful pregnancy after heart-lung transplantation: A case report
50. Metabolites of mercaptopurine in red blood cells: A relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia
51. The mutagenicity of azathioprine in mice, Drosophila melanogaster and Neurospora crassa
52. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
53. Wegener granuloma complicating pregnancy
54. Acute leukemia in pregnancy
55. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy
56. Pregnancy after renal transplantation: Estrogen secretion
57. Induction of chromosomal damage both in vitro and in vivo by 6-mercaptopurine
58. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: Correlation with treatment efficacy
59. Successful pregnancy during chemotherapy for acute leukemia
60. Toward long-term graft survival in renal transplantation: Pregnancy
61. Maternal azathioprine therapy and depressed hemopoiesis in the babies of renal allograft patients
62. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone
63. Transplacental transmission of busulfan (Myleran®) in a mother with leukemia
64. Immunomodulators: Immunosuppressive agents and immunostimulants
65. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey
66. Combination chemotherapy for acute myelocytic leukemia during pregnancy: Three case reports
67. Depressed thymidine kinase activity in zinc-deficient rat embryos
68. DNA synthetic enzyme activities in zinc-deficient embryos
69. Reduced DNA synthesis in zinc deficiency: Regional differences in embryonic rats
70. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues
71. Azathioprine therapy complicated by pregnancy
72. Immunologic evaluation of a neonate born to an immunosuppressed kidney transplant recipient
73. Immunosuppressive drugs and pregnancy
74. Male reproductive capacity may recover following drug treatment with the L-10 protocol for acute lymphocytic leukemia
75. Azathioprine combined with prednisolone or monotherapy with prednisone in active Crohn disease
76. Successful pregnancy after renal transplantation
77. Effect of Imuran® On placental and fetal development in rats
78. Acute leukemia and pregnancy
79. Pregnancy and kidney transplantation: Clinical problems and experience
80. 6-Mercaptopurine (6-MP) is safe therapy for child bearing patients with inflammatory bowel disease (IBD): A case controlled study
81. Acute leukemia and pregnancy
82. Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis
83. Long-term survival (cures) in childhood acute leukemia. Follow-up of nine cases of acute lymphatic leukemia and two of acute myelogenous leukemia with complete remission lasting more than 10 years, three of them with normal progeny
84. Azathioprine teratogenicity: Review of the literature and case report
85. Comparative inducibility by 6-mercaptopurine of dominant-lethal mutations and heritable translocations in early meiotic male germ cells and differentiating spermatogonia of mice
86. 6-Mercaptopurine, an inducer of cytogenetic and dominant lethal effects in premeiotic and early meiotic germ cells of male mice
87. Outcome of lupus pregnancy: A controlled study
88. Schwangerschaff nach nurentransplantation
89. Chromosomal aberrations among offspring of female renal transplant recipients
90. Systemic lupus erythematosus in pregnancy treated with azathioprine
91. Teratogenic effects of azathioprine (Imuran)
92. Fertility after renal transplantation
93. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects
94. Birth defects and childhood cancer in offspring of survivors of childhood cancer
95. Immunosuppressive therapy and breast-feeding after renal transplantation
96. Pregnancy following renal transplantation
97. Pregnancy outcome in renal transplant recipients: Experience at the Medical College of Georgia and review of the literature
98. Updating the approach to Crohn disease
99. Pregnancy outcome in renal allograft recipients in Norway. The importance of immunosuppressive drug regimen and health status before pregnancy
100. Pregnancy in kidney transplant recipients seems successful, but....
101. Management and outcome of pregnancy in autoimmune hepatitis
102. Reversible drug-induced sterility in a patient with acute leukemia
103. Relationship of dietary zinc to 6-mercaptopurine teratogenesis and DNA metabolism in the rat
104. Mutagenicity studies with 6-mercaptopurine: I. Cytogenetic activity in vivo
105. Acute leukemia in pregnancy
106. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants
107. Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients
108. Successful pregnancy in a recipient of a cadaver kidney allograft. Case report and review of the literature
109. Randomized comparison of 6-mercaptopurine vs. 6-thioguanine in maintenance treatment of childhood acute lymphoblastic leukemia (ALL): Differing metabolism and hematologic toxicity
110. Drug treatment of rheumatic diseases during pregnancy. The teratogenicity of antirheumatic drugs - What is the evidence?
111. Successful normal childbirth after kidney homotransplantation
112. Successful pregnancy after cardiac transplantation
113. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A District General Hospital experience
114. Acute leukemia in pregnancy
115. Organ transplantation and pregnancy. A case report and review
116. Conception of normal child during chemotherapy of acute lymphoblastic leukemia in the father
117. Multiple-drug chemotherapy in the management of acute lymphocytic leukemia during pregnancy
118. Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice
119. Teratogenic effects of some purine analogues on fetal rat
120. Pregnancy and liver transplantation
121. Reproductive function and outcome of pregnancy after liver transplantation in women
122. Chromosome aberrations in the child of a kidney transplant recipient
123. Leukemia during pregnancy
124. The clinical pharmacology of 6-mercaptopurine
125. Azathioprine metabolism in kidney transplant recipients
126. Pharmacology of 6-thioguanine in man
127. Ulcerative colitis in pregnancy in Israel
128. Pregnancy outcome following first trimester exposure to chloroquine
129. Progeny of childhood-cancer survivors
130. Problems from immunosuppressives during pregnancy
131. Acute leukemia complicated by pregnancy
132. The role of zinc of growth and cell proliferation
133. Ten model mutagens evaluated by the micronucleus test
134. 6-Thioguanine alters the structure and stability of duplex DNA and inhibits quadruplex DNA formation
135. Factors associated with fetal losses in severe systemic lupus erythematosus
136. Pregnancy following kidney transplantation
137. Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agent
138. A neonatal complication of maternal leukemia treated with 6-mercaptopurine
139. Pregnancy outcomes in female pancreas-kidney recipients
140. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
141. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy
142. Obtention de malformations des membres par la 6-mercaptopurine chez trois espèces: Lapin, rat et souris
143. Resumption of female reproductive function following renal transplantation
144. Complications of pregnancy after renal transplantation including a report of spontaneous uterine rupture
145. Pregnancy in acute leukemia treated with 6-mercaptopurine
146. Progeny of survivors of acute lymphocytic leukemia
147. Pregnancy after heart transplant: Update and case report
148. Acute myelogenous leukemia in pregnancy: Fetal blood sampling and early effects of chemotherapy
149. The genetic toxicology of 6-mercaptopurine
150. Pregnancy outcome in cancer patients. Experience in a large cooperative group
151. Teratogenic effects of tumor-inhibiting chemicals in the rat
152. Childbirth after liver transplantation
153. Pregnancy in renal allograft recipients
154. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine
155. Leukemia complicating pregnancy. Two additional case reports
156. Renal cadaver transplantation followed by successful pregnancies
157. Problems associated with pregnancy in renal allograft recipients
158. Pregnancy after renal transplantation
159. Obstetrical clinics: Acute leukemia and pregnancy
160. Pregnancy following renal transplantation in Class T diabetes mellitus
161. Acute leukemia in pregnancy: Transient neonatal myelosuppression after combination chemotherapy in the mother
162. Immunopharmacological treatment during pregnancy and lactation
163. Two chromosome aberrations in the child of a woman with systemic lupus erythematosus treated with azathioprine and prednisone
164. Childbirth after renal transplantation
165. Pregnancies and offspring in survivors of acute lymphoid leukemia and lymphoma
166. Acute leukemia in pregnancy
167. Pregnancy following lung transplantation
168. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
169. Parenthood following renal transplantation
170. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero
171. Retardation of fetal growth in patients receiving immunosuppressive therapy
172. Treatment of acute leukemia during pregnancy: Presentation of nine cases
173. Teratogenicity induced by 6-mercaptopurine riboside in mice: Possible role of DNA modification during organogenesis
174. DNA modification induced by 6-mercaptopurine riboside in murine embryos
175. Effect of marginal zinc deficiency on human growth and development
176. Treatment of Crohn disease with 6-mercaptopurine. A long-term, randomized, double-blind study
177. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
178. Immunosuppressive drugs and the foetus
179. Successful twin pregnancies in renal transplant recipients taking cyclosporine
180. Pregnancy after liver transplantation: Focusing on risks to the mother
181. Étude de la sensibilité embryonnaire de l'ochotone afghan (Ochotona rufescens rufescens) a deux agents tératogènes, l'azathioprine et la 6 mercaptopurine
182. Association of hypoparathyroidism and successful pregnancy in kidney transplant recipient
183. Monitoring chemically induced DNA damage in the germ cells of male mice
184. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease
185. Immunosuppressive drug use during pregnancy
186. Children of female renal transplant recipients
187. Acute monocytic leukemia in pregnancy. Report of a case treated with 6-mercaptopurine in the first trimester
188. The mutagenic activity of 6-mercaptopurine in host-mediated and dominant-lethal assays
189. Successful pregnancies in women treated by dialysis and kidney transplantation
190. Bi-generational effects of 6-mercaptopurine on reproduction in mice
191. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine s-methyltransferase gene locus
192. Acute leukemia during pregnancy: The Toronto Leukemia Study group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents
193. Passage of leukemic cells across the placenta
194. Analysis of T cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients
195. Azathioprine (Imuran) and pregnancy
196. Acute granulocytic leukemia in pregnancy: Report of four cases, with apparent acceleration by prednisone in one
197. In vitro metabolism of 6-mercaptopurine by human liver cytosol
198. Pregnancy in renal transplant patients: A review
199. Immunosuppression during pregnancy: Transmission of azathioprine and its metabolites from the mother to the fetus
200. Successful pregnancy in renal transplant recipients
201. Pregnancy in renal transplant recipients
202. Azathioprine: State of the art in inflammatory bowel disease
203. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn disease
204. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn disease
205. Pregnancy and kidney transplantation: Experience in a developing country
206. Successful pregnancy during chemotherapy for acute promyelocytic leukemia
207. Childbearing after liver transplantation
208. Dominant lethal test in mice with 6-mercaptopurine
209. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy
210. The use of 6-mercaptopurine in treatment of acute leukemia in late pregnancy
211. Pregnancy following renal transplantation
212. Fetal growth retardation associated with maternal administration of immunosuppressive drugs
213. Pregnancy in heart transplant recipients: Management and outcome
214. Developmental abnormalities induced by 6-mercaptopurine in the hamster
215. Pregnancy and azathioprine in systemic lupus erythematosus
216. Systemic lupus erythematosus in pregnancy treated with mercaptopurine
217. A case of cor triatriatum with end-stage renal Disease: Successful management of open heart surgery under hemodialysis, subsequent renal transplantation and pregnancy
218. Attenuating effect of zinc on abnormal placental morphology in 6-mercaptopurine treated rats
219. Leukemia in pregnancy. A case report
220. Successful pregnancy after combined renal-pancreas transplantation: A case report and literature review
221. Hodgkin disease and pregnancy. Case reports and a discussion of the treatment of Hodgkin disease and leukemia during pregnancy
222. Effects of cancer chemotherapeutic agents on the human fetus
223. Genetic toxicology tests on mizoribine (bredinin). Sister chromatid exchange, chromosomal aberration and mutation tests
224. Leucemia aguda y embarazo
225. A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line
226. Leukemia in pregnancy. A case report of acute lymphatic leukemia
227. Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation
228. Perinatal outcome in renal allograft recipients: Prognostic significance of hypertension and renal function before and during pregnancy
229. Zinc deficient embryos: Reduced thymidine incorporation
230. Dominant-lethal test of 6-mercaptopurine: Dependence on dosage, duration and route of administration
231. Cancer and teratogenesis: Infrequent occurrence after medical use of immunosuppressive drugs
232. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study
233. Thirty successful pregnancies in organ transplant recipients: A single-center experience
234. Birth defects in child of male recipient of kidney transplant
235. The effect of 6-mercaptopurine on the rat fetus and on reproduction of the rat
236. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine
237. Systemic lupus erythematosus and pregnancy: A prospective study
238. Pregnancy after heart or heart-lung transplantation: A series of 10 pregnancies
239. Considérations sur les tests tératogènes. Différences de réaction de trois espèces animales à Íégard un antitumoral
240. Anthracyclines in the treatment of malignancy in pregnancy
241. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis
242. Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration
243. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine
244. Investigation into the mutagenic activity of azathioprine (Imuran®) in different test systems
245. Kidney transplantation and pregnancy
246. Pregnancy following renal transplantation in a patient with insulin-dependent diabetes mellitus
247. Azathioprine, a genotoxic agent to be considered non-genotoxic in man
248. Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus
249. Paternity by cardiac transplant recipients
250. Successful pregnancy in a liver transplant patient
251. Pregnancies after chemotherapy for gestational trophoblastic tumors
252. Successful pregnancy in acute leukemia
253. Methylation pharmacogenetics: Thiopurine methyltransferase as a model system
254. Successful pregnancy with sickle cell disease and renal transplantation
255. Fertility and pregnancy in inflammatory bowel disease
256. Effect of pregnancy on graft function and graft survival in renal cadaver transplant patients
257. Renal transplantation and pregnancy
258. Normal pregnancy in renal transplant recipient with history of eclampsia and intrauterine death
259. Azathioprine teratogenicity: Review of the literature and case report
260. Pregnancy in renal transplant recipients: The Christchurch experience
261. Is pregnancy contraindicated after cardiac transplantation? A case report and literature review
262. Fetal outcome after in utero exposure to cancer chemotherapy
263. Intrauterine contraceptive device failures in renal transplant patients
264. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?